These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15356028)

  • 1. Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis.
    Gonzalez-Calvin JL; Gallego-Rojo F; Fernandez-Perez R; Casado-Caballero F; Ruiz-Escolano E; Olivares EG
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4325-30. PubMed ID: 15356028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.
    Gallego-Rojo FJ; Gonzalez-Calvin JL; Muñoz-Torres M; Mundi JL; Fernandez-Perez R; Rodrigo-Moreno D
    Hepatology; 1998 Sep; 28(3):695-9. PubMed ID: 9731561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis.
    González-Calvin JL; Mundi JL; Casado-Caballero FJ; Abadia AC; Martin-Ibañez JJ
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4844-50. PubMed ID: 19897681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical study of abnormal bone metabolism in patients with HBV liver cirrhosis].
    Wang YG; Liu Q; Wang WQ; Chen ZP; Yan MX
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):33-6. PubMed ID: 16420762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between adipokines and the development of osteopenic syndrome in end-stage lung disease].
    Kochetkova EA; Ugaĭ LG; Buria KA; Nevzorova VA; Massard J
    Ter Arkh; 2012; 84(12):40-4. PubMed ID: 23479987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RANKL/OPG system and bone mineral density in patients with chronic liver disease.
    Moschen AR; Kaser A; Stadlmann S; Millonig G; Kaser S; Mühllechner P; Habior A; Graziadei I; Vogel W; Tilg H
    J Hepatol; 2005 Dec; 43(6):973-83. PubMed ID: 16143421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.
    Schiefke I; Fach A; Wiedmann M; Aretin AV; Schenker E; Borte G; Wiese M; Moessner J
    World J Gastroenterol; 2005 Mar; 11(12):1843-7. PubMed ID: 15793878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis.
    Tsuneoka K; Tameda Y; Takase K; Nakano T
    J Gastroenterol; 1996 Oct; 31(5):669-78. PubMed ID: 8887033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt.
    Raslan HM; Elhosary Y; Ezzat WM; Rasheed EA; Rasheed MA
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):429-32. PubMed ID: 20189618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis.
    Franck H; Meurer T; Hofbauer LC
    J Rheumatol; 2004 Nov; 31(11):2236-41. PubMed ID: 15517638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver.
    Shiomi S; Nishiguchi S; Kubo S; Tamori A; Habu D; Takeda T; Ochi H
    Am J Gastroenterol; 2002 Apr; 97(4):978-81. PubMed ID: 12003435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of osteoporosis in patients with cirrhosis due to hepatitis B and hepatitis C: a study of 100 cases.
    Javed M; Saeed A; Khan IM; Hameed K; Rehman S; Khattak AK; Ahmad I; Khan SA
    J Ayub Med Coll Abbottabad; 2009; 21(3):51-3. PubMed ID: 20929012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Tumor Necrosis Factor Alpha and TNF Superfamily Members in Bone Damage in Patients with End-Stage Chronic Obstructive Lung Disease Prior to Lung Transplantation.
    Kochetkova EA; Nevzorova VA; Ugai LG; Maistrovskaia YV; Massard G
    Calcif Tissue Int; 2016 Dec; 99(6):578-587. PubMed ID: 27501819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
    Street ME; Spaggiari C; Ziveri MA; Volta C; Federico G; Baroncelli GI; Bernasconi S; Saggese G
    Horm Res; 2006; 66(4):162-8. PubMed ID: 16804317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between circulating tumor necrosis factor system and bone mass before and after estrogen plus progestogen therapy.
    Kim JG; Ku SY; Kim H; Chun SW; Suh CS; Choi YM
    Menopause; 2009; 16(3):534-8. PubMed ID: 19225428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of soluble tumor necrosis factor-p55 levels in the serum and ascitic fluid of patients with hepatocellular carcinoma.
    Gao L; Bai L; Nan QZ; Yang XS; Chen K; Wen HP; Lai ZS; Bo L; Zhang YL; Zhang ZS
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):641-3. PubMed ID: 12376300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder.
    Kahl KG; Rudolf S; Stoeckelhuber BM; Dibbelt L; Gehl HB; Markhof K; Hohagen F; Schweiger U
    Am J Psychiatry; 2005 Jan; 162(1):168-74. PubMed ID: 15625216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
    Chlebna-Sokol D; Rusinska A
    Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study.
    Mahmoudi A; Sellier N; Reboul-Marty J; Chalès G; Lalatonne Y; Bourcier V; Grando V; Barget N; Beaugrand M; Trinchet JC; Ganne-Carrié N
    Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):731-7. PubMed ID: 21873139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.